MedPath
HSA Approval

MIXTARD 30 INJECTION 100 iu/ml

SIN08656P

MIXTARD 30 INJECTION 100 iu/ml

MIXTARD 30 INJECTION 100 iu/ml

April 16, 1996

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

Regulatory Information

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

Therapeutic

Pharmacy Only

Formulation Information

INJECTION

_**3\. How to use Mixtard®**_ Talk about your insulin needs with your doctor and nurse. Follow their advice carefully. If your doctor has switched you from one type or brand of insulin to another, your dose may have to be adjusted by your doctor. Eat a meal or snack containing carbohydrates within 30 minutes of the injection. It is recommended that you measure your blood sugar regularly. **How to use this insulin** **Mixtard® is administered by injection under the skin** (subcutaneously). Never inject your insulin directly into a vein or muscle. Always vary the sites you inject within the same region, to reduce the risk of developing lumps or skin pitting (see _5 Possible side effects_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). The best places to give yourself an injection are: the front of your waist (abdomen); your buttocks; the front of your thighs or upper arms. Your insulin will work more quickly if you inject it around the waist. **How to inject Mixtard®** - **Make sure you have the correct syringe** with the corresponding unit scale for insulin injections. - **Draw air into the syringe,** in the same amount as the dose of insulin you need. - **Follow the instructions** given by your doctor or nurse. - **Just before injecting this insulin,** roll the vial between your hands until the liquid is uniformly white and cloudy. Resuspending is easier if the insulin has reached room temperature. - **Inject the insulin** under the skin. Use the injection technique advised by your doctor or nurse. - **Keep the needle under your skin** for at least 6 seconds to make sure that the full dose has been delivered.

SUBCUTANEOUS

Medical Information

_**1\. What Mixtard® is and what it is used for**_ **Mixtard® is human insulin used to treat diabetes.** Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of your blood sugar. Mixtard® is a mixture of fast-acting insulin and long-acting insulin. This means that it will start to lower your blood sugar about ½ hour after you take it, and the effect will last for approximately 24 hours.

_**2\. Before you use Mixtard®**_ **Do not use Mixtard®** - **In insulin infusion pumps.** - **If you are allergic (hypersensitive)** to human insulin or any of the other ingredients in Mixtard® (see _7 Further information_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). - **If you suspect hypoglycaemia** (low blood sugar) is starting (see _4 What to do in an emergency_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). - **If the protective cap is loose or missing.** Each vial has a protective, tamper-proof plastic cap. If it is not in perfect condition when you get the vial, return the vial to your pharmacy. - **If it has not been stored correctly** or been frozen (see _6 How to store Mixtard®_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). - **If the resuspended insulin does not appear uniformly white and cloudy.**

A10AD01

insulin (human)

Manufacturer Information

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

Novo Nordisk A/S

Novo Nordisk Production SAS

Active Ingredients

Insulin Human, rDNA (as soluble insulin)

30IU/ml

Insulin human

Insulin Human, rDNA (as isophane insulin)

70IU/ml

Insulin human

Documents

Patient Information Leaflets

Mixtard 30 Vial Injection PIL.pdf

Approved: October 28, 2021

Download
© Copyright 2025. All Rights Reserved by MedPath
MIXTARD 30 INJECTION 100 iu/ml - HSA Approval | MedPath